Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Market price (% of par)
-
92.31%
-
Total 13F principal
-
$152,469,254
-
Principal change
-
-$15,894,150
-
Total reported market value
-
$187,829,878
-
Number of holders
-
18
-
Value change
-
+$194,776
-
Number of buys
-
8
-
Number of sells
-
8
Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q2 2024
As of 30 Jun 2024,
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 was held by
18 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$152,469,254
in principal (par value) of the bond.
The largest 10 bondholders included
Davidson Kempner Capital Management LP, HIGHBRIDGE CAPITAL MANAGEMENT LLC, WHITEBOX ADVISORS LLC, Two Seas Capital LP, Pentwater Capital Management LP, Whitefort Capital Management, LP, AMERIPRISE FINANCIAL INC, Point72 Asset Management, L.P., Jefferies Financial Group Inc., and AGF MANAGEMENT LTD.
This page lists
18
institutional bondholders reporting positions
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.